Literature DB >> 20967186

Therapeutic and Aesthetic Uses of Photodynamic Therapy Part five of a five-part series: ALA-PDT in Clinical Practice How One Clinician Performs This Procedure.

Michael H Gold1.   

Abstract

The use of 5-aminolevulinic acid-photodynamic therapy in clinical practice is an individual determination based on experiences learned from clinicians and from personal experience. This manuscript reviews how one clinician approaches patients interested in having photodynamic therapy. It covers all practical aspects of the treatment process and reviews how photodynamic therapy can be utilized in your clinical practice.

Entities:  

Year:  2009        PMID: 20967186      PMCID: PMC2958187     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  16 in total

1.  Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial.

Authors:  S R Wiegell; H C Wulf
Journal:  Br J Dermatol       Date:  2006-05       Impact factor: 9.302

Review 2.  5-aminolevulinic acid photodynamic therapy: where we have been and where we are going.

Authors:  Michael H Gold; Mitchel P Goldman
Journal:  Dermatol Surg       Date:  2004-08       Impact factor: 3.398

3.  5-Aminolevulinic acid photodynamic therapy versus methyl aminolevulinate photodynamic therapy for inflammatory acne vulgaris.

Authors:  Michael H Gold
Journal:  J Am Acad Dermatol       Date:  2008-02       Impact factor: 11.527

4.  Fractionated aminolevulinic acid-photodynamic therapy (PDT) provides additional evidence for the use of PDT for non-melanoma skin cancer.

Authors:  M H Gold
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-05       Impact factor: 6.166

5.  A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy.

Authors:  Michael H Gold; Julie Biron
Journal:  J Drugs Dermatol       Date:  2006-09       Impact factor: 2.114

6.  Enhanced efficacy of photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation.

Authors:  Ricardo Ruiz-Rodriguez; Laura López; Daniel Candelas; Brian Zelickson
Journal:  J Drugs Dermatol       Date:  2007-08       Impact factor: 2.114

7.  Photodynamic photorejuvenation.

Authors:  R Ruiz-Rodriguez; T Sanz-Sánchez; S Córdoba
Journal:  Dermatol Surg       Date:  2002-08       Impact factor: 3.398

8.  Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation.

Authors:  J-Y Fang; W-R Lee; S-C Shen; Y-P Fang; C-H Hu
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

9.  A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.

Authors:  Dany Touma; Mina Yaar; Sara Whitehead; Nellie Konnikov; Barbara A Gilchrest
Journal:  Arch Dermatol       Date:  2004-01

10.  Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.

Authors:  David Pariser; Robert Loss; Michael Jarratt; William Abramovits; James Spencer; Roy Geronemus; Philip Bailin; Suzanne Bruce
Journal:  J Am Acad Dermatol       Date:  2008-08-15       Impact factor: 11.527

View more
  2 in total

1.  Therapeutic and Aesthetic Uses of Photodynamic Therapy Part five of a five-part series: ALA-PDT and MAL-PDT What Makes Them Different.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2009-02

Review 2.  Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

Authors:  Nathalie C Zeitouni; Neal Bhatia; Roger I Ceilley; Joel L Cohen; James Q Del Rosso; Angela Y Moore; Gilly Munavalli; David M Pariser; Todd Schlesinger; Daniel M Siegel; Andrea Willey; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2021-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.